Thomas Schatton is an experienced professional currently serving as a Gesellschafter at savvytec since March 2022 and as the CEO of Four 20 Pharma GmbH since January 2021. Prior to these roles, Thomas held the position of Geschäftsführender Gesellschafter at W-AYS GmbH & Co. KG from December 2012 to March 2022, demonstrating a strong background in leadership and management across various sectors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices